(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-08 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 1002740
Date | Daily Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 92.30 | 92.18 | 94.72 | 91.93 | 0.672 times |
07 Thu Mar 2024 | 92.04 | 90.37 | 92.75 | 89.73 | 1.466 times |
06 Wed Mar 2024 | 90.38 | 89.00 | 91.78 | 88.92 | 0.783 times |
05 Tue Mar 2024 | 89.67 | 89.41 | 90.84 | 88.55 | 0.6 times |
04 Mon Mar 2024 | 90.80 | 95.26 | 96.30 | 90.39 | 0.623 times |
01 Fri Mar 2024 | 95.12 | 93.81 | 98.06 | 93.73 | 0.789 times |
29 Thu Feb 2024 | 93.52 | 98.82 | 98.82 | 92.95 | 0.715 times |
28 Wed Feb 2024 | 95.45 | 98.15 | 101.00 | 95.27 | 0.985 times |
27 Tue Feb 2024 | 99.79 | 95.00 | 99.87 | 95.00 | 1.722 times |
26 Mon Feb 2024 | 95.05 | 89.89 | 95.57 | 89.14 | 1.287 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 95.5 as stoploss in an intra day sell trade for a target of 88.5. However, stock will show a bullish move above 95.5.
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 56.75 |
Downside Target | 68.28 |
Downside Target | 71.50 |
Downside Target | 75.20 |
Downside Target | 78.91 |
Downside Target | 88.55 |
Upside Target | 92.88 |
Upside Target | 94.00 |
Upside Target | 94.47 |
Upside Target | 96.30 |
Upside Target | 98.06 |
Upside Target | 101.00 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 88.47 |
Downside Intraday Target | 84.63 |
Upside Intraday Target | 96.22 |
Upside Intraday Target | 100.13 |
Upside Intraday Target | 92.38 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 92.30 | 95.26 | 96.30 | 88.55 | 0.754 times |
01 Fri Mar 2024 | 95.12 | 89.89 | 101.00 | 89.14 | 1.111 times |
23 Fri Feb 2024 | 89.49 | 88.98 | 92.88 | 80.42 | 0.961 times |
16 Fri Feb 2024 | 90.26 | 77.22 | 94.47 | 72.24 | 1.236 times |
09 Fri Feb 2024 | 76.54 | 78.14 | 78.91 | 72.73 | 1.332 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 92.30 | 93.81 | 98.06 | 88.55 | 0.25 times |
29 Thu Feb 2024 | 93.52 | 79.33 | 101.00 | 72.24 | 1.428 times |
31 Wed Jan 2024 | 79.53 | 90.54 | 93.07 | 75.20 | 0.637 times |
29 Fri Dec 2023 | 92.24 | 69.40 | 94.00 | 68.28 | 1.507 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.19 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.19 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.